Forwarders need to be specialists to make pharma work
SME forwarders looking to enter pharmaceutical logistics should avoid competing directly with multinationals and instead focus on building specialist capabilities, says Pharma.Aero secretary general Frank van Gelder. Rising demand from clinical trials and time-critical…
SME forwarders looking to enter pharmaceutical logistics should avoid competing directly with multinationals and instead focus on building specialist capabilities, says Pharma.Aero secretary general Frank van Gelder.
Rising demand from clinical trials and time-critical healthcare shipments, together with the emergence of advanced therapies, is creating opportunities for SMEs, but Mr van Gelder said operators must demonstrate the requisite expertise, systems quality and dependability.
He told The Loadstar: “SME forwarders should become indispensable specialists. The opportunities are in clinical trials, time-critical healthcare, advanced therapies, specialised regional corridors and high-touch services around research centres and hospitals.
“An SME can combine local knowledge, quick decision-making and trusted international partners. Emerging connections with Chinese and Indian innovation ecosystems can create further possibilities, provided operators build real expertise rather than simply market a new lane.”
This story was originally published by The Loadstar. Read the full story at The Loadstar →




Conversation